Helicobacter Pylori Virulence Factor Cytotoxin-Associated Gene A (CagA) Induces Vascular Calcification in Coronary

Martin O Sundqvist1,2, Jonatan Wärme1,2, Robin Hofmann1,2

  • 1Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, SE-118 83 Stockholm, Sweden.

Insights

Helicobacter pylori (H. pylori) infection may contribute to vascular calcification. The H. pylori CagA protein promotes osteogenic changes and calcification in coronary artery smooth muscle cells, indicating a potential cardiovascular risk.

Area of Science:

  • Cardiovascular Biology
  • Microbiology
  • Cellular Biology

Background:

  • Helicobacter pylori (H. pylori) infection is linked to cardiovascular diseases.
  • The H. pylori virulence factor CagA is found in serum exosomes and may have systemic cardiovascular effects.
  • The specific role of H. pylori and CagA in vascular calcification remains unclear.

Purpose of the Study:

  • To investigate the vascular effects of CagA in human coronary artery smooth muscle cells (CASMCs).
  • To assess CagA's impact on CASMC osteogenic gene expression, cellular calcification, and inflammatory responses.

Main Methods:

  • Cultured human coronary artery smooth muscle cells (CASMCs).
  • Exposed CASMCs to CagA.
  • Measured osteogenic gene expression (e.g., BMP-2), interleukin-1β secretion, and cellular calcification.

Main Results:

  • CagA upregulated bone morphogenic protein 2 (BMP-2) expression.
  • CagA induced an osteogenic phenotype switch in CASMCs.
  • CagA exposure led to increased cellular calcification and a pro-inflammatory response.

Conclusions:

  • H. pylori CagA promotes osteogenic transformation and calcification in CASMCs.
  • CagA contributes to vascular calcification through inducing an osteogenic phenotype and inflammation.
  • H. pylori infection may play a role in the pathogenesis of vascular calcification via CagA.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
654
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
482
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
617
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
234
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19